TrialsgrambetaRCTs are beautiful

SYNTAX

2009

SYNergy between percutaneous coronary intervention with TAXUS and Cardiac Surgery

In 1,800 patients with 3-vessel or left main coronary disease, PCI with paclitaxel-eluting stents increased 12-month death, stroke, MI, or repeat revascularisation compared with CABG.

Result

MACCE (death, stroke, MI, or repeat revascularisation) at 12 months
Absolute difference
5.4 points
NNH
19

Absolute difference and NNH are derived from the event rates.

Also reported: Non-inferiority not met, driven by more repeat revascularisation with PCI (13.5% vs 5.9%). Stroke higher with CABG (2.2% vs 0.6%).

Original publication
Subtopic
PCI vs CABG
Design
Multicentre all-comers RCT, non-inferiority
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Serruys PW, et al. N Engl J Med. 2009;360(10):961-72.doi 10.1056/NEJMoa0804626

Discussion & critique

Used obsolete first-generation paclitaxel stents and failed a non-inferiority design, so not a clean superiority test. Established the anatomic SYNTAX score and the Heart Team principle that CABG is preferred for complex 3-vessel/left-main disease.

Discussed in podcasts